Dariohealth Corp Stock EBITDA
| DRIO Stock | USD 0.79 0.07 9.72% |
DarioHealth Corp fundamentals help investors to digest information that contributes to DarioHealth Corp's financial success or failures. It also enables traders to predict the movement of DarioHealth Stock. The fundamental analysis module provides a way to measure DarioHealth Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DarioHealth Corp stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -54.4 M | -51.7 M |
DarioHealth | EBITDA |
DarioHealth Corp Company EBITDA Analysis
DarioHealth Corp's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current DarioHealth Corp EBITDA | (54.38 M) |
Most of DarioHealth Corp's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DarioHealth Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
DarioHealth EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for DarioHealth Corp is extremely important. It helps to project a fair market value of DarioHealth Stock properly, considering its historical fundamentals such as EBITDA. Since DarioHealth Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DarioHealth Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DarioHealth Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
DarioHealth Ebitda
According to the company disclosure, DarioHealth Corp reported earnings before interest,tax, depreciation and amortization of (54.38 Million). This is 106.2% lower than that of the Health Care Equipment & Supplies sector and 115.68% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.39% higher than that of the company.
DarioHealth EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DarioHealth Corp's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DarioHealth Corp could also be used in its relative valuation, which is a method of valuing DarioHealth Corp by comparing valuation metrics of similar companies.DarioHealth Corp is currently under evaluation in ebitda category among its peers.
DarioHealth Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of DarioHealth Corp from analyzing DarioHealth Corp's financial statements. These drivers represent accounts that assess DarioHealth Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of DarioHealth Corp's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 14.9M | 85.2M | 215.2M | 101.2M | 48.8M | 37.0M | |
| Enterprise Value | (4.8M) | 57.2M | 179.7M | 79.8M | 41.5M | 27.6M |
DarioHealth Corp Institutional Holders
Institutional Holdings refers to the ownership stake in DarioHealth Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of DarioHealth Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing DarioHealth Corp's value.| Shares | Renaissance Technologies Corp | 2024-09-30 | 87.7 K | Ubs Group Ag | 2024-06-30 | 77.3 K | State Street Corp | 2024-06-30 | 75 K | Northern Trust Corp | 2024-09-30 | 69.5 K | Citadel Advisors Llc | 2024-09-30 | 66.4 K | Susquehanna International Group, Llp | 2024-06-30 | 38.4 K | Xtx Topco Ltd | 2024-09-30 | 29.5 K | Clarity Capital Partners Llc | 2024-09-30 | 28.2 K | Bank Of Montreal | 2024-06-30 | 25.5 K | Nantahala Capital Management, Llc | 2024-09-30 | 2.5 M | Appian Way Asset Management | 2024-09-30 | 1.4 M |
DarioHealth Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.35 | ||||
| Profit Margin | (2.06) % | ||||
| Operating Margin | (1.62) % | ||||
| Current Valuation | 39.5 M | ||||
| Shares Outstanding | 34.1 M | ||||
| Shares Owned By Insiders | 17.71 % | ||||
| Shares Owned By Institutions | 23.57 % | ||||
| Number Of Shares Shorted | 1.92 M | ||||
| Price To Earning | (2.30) X | ||||
| Price To Book | 0.42 X | ||||
| Price To Sales | 1.07 X | ||||
| Revenue | 20.35 M | ||||
| Gross Profit | 14.01 M | ||||
| EBITDA | (54.38 M) | ||||
| Net Income | (59.43 M) | ||||
| Cash And Equivalents | 67.95 M | ||||
| Cash Per Share | 2.96 X | ||||
| Total Debt | 29.54 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 6.35 X | ||||
| Book Value Per Share | 1.87 X | ||||
| Cash Flow From Operations | (30.38 M) | ||||
| Short Ratio | 30.76 X | ||||
| Earnings Per Share | (0.93) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 276 | ||||
| Beta | 1.51 | ||||
| Market Capitalization | 24.56 M | ||||
| Total Asset | 96.39 M | ||||
| Retained Earnings | (349.36 M) | ||||
| Working Capital | 34.84 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 1.69 M | ||||
| Net Asset | 96.39 M |
About DarioHealth Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DarioHealth Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DarioHealth Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DarioHealth Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against DarioHealth Stock
| 0.73 | GH | Guardant Health | PairCorr |
| 0.64 | LH | Laboratory | PairCorr |
| 0.57 | DXCM | DexCom Inc Sell-off Trend | PairCorr |
| 0.49 | VREX | Varex Imaging Corp | PairCorr |
| 0.43 | VEEV | Veeva Systems Class Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out DarioHealth Corp Piotroski F Score and DarioHealth Corp Altman Z Score analysis. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.93) | Revenue Per Share 0.631 | Quarterly Revenue Growth 1.11 | Return On Assets (0.35) | Return On Equity (0.75) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.